October 27, 2005

Former FDA Commissioner or Wife Held Stock in FDA Regulated Area – NYT

Former FDA Commissioner or Wife Held Stock in FDA Regulated Area – NYT Thu, 27 Oct 2005

Read More
Former FDA Commissioner or Wife Held Stock in FDA Regulated Area – NYT

June 8, 2005

Grassley Pushes FDA: Transparency, Accountability & Independence / Whistleblowers are essential Witnesses

Grassley Pushes FDA: Transparency, Accountability & Independence / Whistleblowers are essential Witnesses Wed, 8 Jun 2005 The

Read More
Grassley Pushes FDA: Transparency, Accountability & Independence / Whistleblowers are essential Witnesses

April 24, 2005

Vioxx Fallout: Merck Officials Intervened–NYT / FDA Officials Intervened–Mother Jones

Vioxx Fallout: Merck Officials Intervened–NYT / FDA Officials Intervened–Mother Jones Mon, 25 Apr 2005 Mother Jones and

Read More
Vioxx Fallout: Merck Officials Intervened–NYT / FDA Officials Intervened–Mother Jones

March 29, 2005

AHRP Ethical and Scientific Objections to FDA’s Proposed Licensure of Anthrax Vaccine

Cover Letter March 29, 2005 Lester Crawford, Ph.D., D.V.M. Acting FDA Commissioner U. S. Food and Drug

Read More
AHRP Ethical and Scientific Objections to FDA’s Proposed Licensure of Anthrax Vaccine

March 10, 2005

What Ails the FDA? Payola – Marcia Angell Boston Globe

What Ails the FDA? Payola – Marcia Angell Boston Globe Thu, 10 Mar 2005 The Boston Globe

Read More
What Ails the FDA? Payola – Marcia Angell Boston Globe

February 17, 2005

FDA Panel Poses Pointed Questions to Drug Makers Over Risks of Painkillers – NYT

FDA Panel Poses Pointed Questions to Drug Makers Over Risks of Painkillers – NYT Thu, 17 Feb

Read More
FDA Panel Poses Pointed Questions to Drug Makers Over Risks of Painkillers – NYT

February 12, 2005

Drug Regulators Are Trying to Quash Study, Senator Says

THE NEW YORK TIMES February 12, 2005 Drug Regulators Are Trying to Quash Study, Senator Says By

Read More
Drug Regulators Are Trying to Quash Study, Senator Says

November 16, 2004

FDA Chief Counsel, Daniel Troy, Resigned

FDA Chief Counsel, Daniel Troy, Resigned Wed, 17 Nov 2004 FDA’s chief counsel, Daniel Troy, has resigned!

Read More
FDA Chief Counsel, Daniel Troy, Resigned

November 1, 2004

Complaint to FDA: Pfizer Failed to Disclose Zoloft Suicide Risk in NYT Adverstisement

Complaint to FDA: Pfizer Failed to Disclose Zoloft Suicide Risk in NYT Adverstisement Mon, 1 Nov 2004

Read More
Complaint to FDA: Pfizer Failed to Disclose Zoloft Suicide Risk in NYT Adverstisement

September 11, 2004

AHRP Press Briefing Re: Antidepressant Drug Risks

ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) 142 West End Ave. Suite 28P, New York, NY 10023 ***PRESS

Read More
AHRP Press Briefing Re: Antidepressant Drug Risks

July 13, 2004

Cong Hinchey Rebukes Daniel Troy, Chief Counsel FDA, for financial conflict of interest

Cong Hinchey Rebukes Daniel Troy, Chief Counsel FDA, for financial conflict of interest Tue, 13 Jul 2004

Read More
Cong Hinchey Rebukes Daniel Troy, Chief Counsel FDA, for financial conflict of interest

May 1, 2004

Cong. Hinchey calls for ouster of FDA Counsel – Sen. Bingaman & Reed tell FDA: disclose all trial info

Cong. Hinchey calls for ouster of FDA Counsel Sen. Bingaman & Reed tell FDA: disclose all trial

Read More
Cong. Hinchey calls for ouster of FDA Counsel – Sen. Bingaman & Reed tell FDA: disclose all trial info